KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Inventory (2016 - 2026)

West Pharmaceutical Services has reported Inventory over the past 18 years, most recently at $452.6 million for Q1 2026.

  • Quarterly Inventory rose 16.44% to $452.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $452.6 million through Mar 2026, up 16.44% year-over-year, with the annual reading at $443.9 million for FY2025, 17.75% up from the prior year.
  • Inventory was $452.6 million for Q1 2026 at West Pharmaceutical Services, up from $443.9 million in the prior quarter.
  • Over five years, Inventory peaked at $452.6 million in Q1 2026 and troughed at $377.0 million in Q4 2024.
  • The 5-year median for Inventory is $421.1 million (2025), against an average of $423.0 million.
  • Biggest five-year swings in Inventory: soared 34.27% in 2022 and later dropped 13.27% in 2024.
  • Tracing WST's Inventory over 5 years: stood at $414.8 million in 2022, then rose by 4.8% to $434.7 million in 2023, then fell by 13.27% to $377.0 million in 2024, then rose by 17.75% to $443.9 million in 2025, then rose by 1.96% to $452.6 million in 2026.
  • According to Business Quant data, Inventory over the past three periods came in at $452.6 million, $443.9 million, and $438.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.